ETF · NYSE Arca: THNR
THNR — Amplify Weight Loss Drug & Treatment ETF
Amplify Weight Loss Drug & Treatment ETF (THNR) is an exchange-traded fund listed on NYSE Arca. On Bright Analyst you can analyze THNR's holdings, sector allocation, performance, expense ratio, dividends and similar ETFs, alongside an AI-written fund analysis.
Key facts
- Ticker symbol
- THNR
- Exchange
- NYSE Arca
- ISIN
- US0321085328
- Security type
- Exchange-traded fund
Research THNR
- Price Chart — Interactive price history with AI commentary.
- Fund Analysis — Fund profile, strategy, index and an AI-written analysis.
- Performance — Returns, valuation and expense ratio against its category.
- Holdings — Every position with its weight, sector and asset type.
- Allocation — Sector, asset-class and top-holding concentration.
- Peers — Comparison with similar ETFs on cost, returns and holdings.
- Dividends — Dividend yield and distribution history.
- News — Latest headlines about the fund and its issuer.
Frequently asked questions
What is the THNR ETF?
THNR is the ticker symbol of Amplify Weight Loss Drug & Treatment ETF, an exchange-traded fund listed on NYSE Arca with ISIN US0321085328.
What does THNR hold?
The THNR Holdings page lists every position in Amplify Weight Loss Drug & Treatment ETF with its portfolio weight, and the Allocation page breaks the fund down by sector and asset class.
Does THNR pay a dividend?
The THNR Dividends page shows the fund's dividend yield and distribution history for any period in which it has paid distributions.
What are alternatives to THNR?
The THNR Peers page compares Amplify Weight Loss Drug & Treatment ETF with similar ETFs on cost, performance and holdings.
For information only — not investment advice.